AngioWaveNet vs Cardiomo
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization lab requires enhanced visualization of fluoroscopic angiograms to improve diagnostic accuracy and procedural guidance. This AI software integrates seamlessly with existing workflows and is compatible with any angiography system, providing clearer images of blood vessels and anatomical features.
View AngioWaveNet →Choose Cardiomo if…
Choose Cardiomo if you need a comprehensive, continuous, and remote heart health monitoring solution for patients, especially for early detection of cardiovascular diseases and timely alerts. This medical-grade wearable device tracks vital signs and uses AI to provide real-time notifications to users and caregivers, making it ideal for managing chronic conditions and preventing critical events.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Cardiomo |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Contact for pricing |
| Deployment | Cloud-based or on-premise/servers | Cloud-based with wearable device and mobile app |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo, with its wearable patch and mobile app, appears to offer a more straightforward and accessible user experience for continuous remote monitoring, especially for patients and caregivers. AngioWaveNet, while designed to integrate into existing Cath lab workflows with minimal training, still operates within a complex clinical environment requiring specialized personnel.
Clinical Value
AngioWaveNetAngioWaveNet is FDA-cleared software that directly enhances the visualization of fluoroscopic angiograms, which is critical for diagnostic accuracy and procedural guidance in cardiac catheterization laboratories. Cardiomo, while providing continuous monitoring and alerts, is a medical-grade wearable device that has received ISO 13485 certification, and has undergone pilot projects and clinical validation studies in several countries, but its FDA approval status is still pending.
Pricing & Value
TieAngioWaveNet offers annual software licensing or subscription-based access with custom packages, which is standard for enterprise-level medical software. Cardiomo's current pricing is not publicly available, though it was previously offered at $200 with a $10 monthly subscription, making a direct comparison of value difficult without more transparent information for both.
Enterprise Readiness
AngioWaveNetAngioWaveNet is designed for integration into existing Cath lab workflows and is compatible with any fluoroscopic angiography system, indicating a strong focus on enterprise deployment within hospital systems. Cardiomo, while offering a HIPAA-compliant cloud platform and B2B/B2B2C models, is primarily a wearable device solution that may require different considerations for large-scale enterprise integration beyond remote patient monitoring programs.
Innovation
TieAngioWaveNet utilizes AI-powered spatiotemporal enhancement processing (STEP) to improve vessel visualization in a mature technology area, which is a significant innovation for interventional cardiology. Cardiomo offers a medical-grade wearable with AI-powered continuous vital sign monitoring and real-time alerts for cardiovascular events, representing innovation in remote patient monitoring and preventative care. Both bring distinct, valuable innovations to their respective domains within cardiology.
Support & Docs
CardiomoCardiomo provides comprehensive documentation including mobile app user manuals, a dashboard user guide, API reference, integration guides, and clinical/research documentation, all readily available for download. AngioWaveNet mentions minimal training and cybersecurity measures, but specific details on publicly accessible support documentation are less prominent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Cardiomo |
|---|---|---|
| Name | AngioWaveNet | Cardiomo |
| Company | Angiowave Imaging | Cardiomo, Inc. |
| Description | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | A medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Primary Function | AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for improved vessel visualization in fluoroscopic angiograms | Continuous vital sign monitoring and AI-powered disease detection (arrhythmias, cardiovascular events) with real-time alerts |
| Specialties | Cardiology, Interventional Radiology, Vascular Surgery | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Cardiomo.